SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-14-017615
Filing Date
2014-03-25
Accepted
2014-03-25 16:06:32
Documents
6
Period of Report
2014-03-21
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v372596_8k.htm 8-K 20691
2 EXHIBIT 99.1 v372596_ex99-1.htm EX-99.1 21731
3 EXHIBIT 99.2 v372596_ex99-2.htm EX-99.2 16438
4 GRAPHIC image_001.jpg GRAPHIC 3230
5 GRAPHIC image_002.jpg GRAPHIC 2969
6 GRAPHIC image_003.jpg GRAPHIC 2968
  Complete submission text file 0001144204-14-017615.txt   73043
Mailing Address 3000 KENT AVE STE A1-100 WEST LAFAYETTE IN 47906
Business Address 3000 KENT AVE STE A1-100 WEST LAFAYETTE IN 47906 7654637175
ENDOCYTE INC (Filer) CIK: 0001235007 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35050 | Film No.: 14716062
SIC: 2834 Pharmaceutical Preparations